Lixivaptan for hyponatremia
Bowman BT, Rosner MH (Source: Core Evidence)
Source: Core Evidence - July 11, 2013 Category: Drugs & Pharmacology Source Type: research
Ibrutinib in advanced CLL
Chavez JC, Sahakian E, Pinilla-Ibarz J (Source: Core Evidence)
Source: Core Evidence - May 16, 2013 Category: Drugs & Pharmacology Source Type: research
Enzalutamide for prostate cancer
Golshayan AR, Antonarakis ES (Source: Core Evidence)
Source: Core Evidence - April 3, 2013 Category: Drugs & Pharmacology Source Type: research
Obatoclax and hematological malignancies
Goard CA, Schimmer AD (Source: Core Evidence)
Source: Core Evidence - March 14, 2013 Category: Drugs & Pharmacology Source Type: research
HEBRT versus CEBRT in localized prostate cancer
Botrel TEA, Clark O, Pompeo ACL, Bretas FFH, Sadi MV, Ferreira U, dos Reis RB (Source: Core Evidence)
Source: Core Evidence - March 6, 2013 Category: Drugs & Pharmacology Source Type: research
Linezolid for treating MRSA infections
Watkins RR, Lemonovich TL, File Jr TM (Source: Core Evidence)
Source: Core Evidence - December 10, 2012 Category: Drugs & Pharmacology Source Type: research
Polifeprosan 20 with carmustine implant wafers
Kleinberg L (Source: Core Evidence)
Source: Core Evidence - October 25, 2012 Category: Drugs & Pharmacology Source Type: research
Icatibant in acute angioedema attack
Floccard B, Hautin E, Bouillet L, Coppere B, Allaouchiche B (Source: Core Evidence)
Source: Core Evidence - September 27, 2012 Category: Drugs & Pharmacology Source Type: research
Rindopepimut for the treatment of glioblastoma
Babu R, Adamson DC (Source: Core Evidence)
Source: Core Evidence - September 14, 2012 Category: Drugs & Pharmacology Source Type: research
Pancrelipase and pancreatic exocrine insufficiency
Nakajima K, Oshida H, Muneyuki T, Kakei M (Source: Core Evidence)
Source: Core Evidence - July 19, 2012 Category: Drugs & Pharmacology Source Type: research
